Moxonidine hydrochloride
Moxonidine hydrochloride Basic information
- Product Name:
- Moxonidine hydrochloride
- Synonyms:
-
- MOXONIDINE HYDROCHLORIDE
- MOXONIDINE HCL
- BDF-5895 HCL
- 4-CHLORO-6-METHOXY-2-METHYL-5-(2-IMIDAZOLIN-2-YL)AMINOPYRIMIDINE HCL
- 4-CHLORO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-6-METHOXY-2-METHYL-5-PYRIMIDINAMINE HYDROCHLORIDE
- MoxonidineHclC9H12C1N50.HC1
- 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-3H-pyrimidin-2-amine hydrochloride
- 6-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-4-methoxy-2-methyl-1H-pyrimidin-2-amine hydrochloride
- CAS:
- 75438-58-3
- MF:
- C9H13Cl2N5O
- MW:
- 278.14
- Product Categories:
-
- Imidazoline binding site
- Antihypertensive
- Mol File:
- 75438-58-3.mol
Moxonidine hydrochloride Chemical Properties
- Melting point:
- 189°
- CAS DataBase Reference
- 75438-58-3(CAS DataBase Reference)
MSDS
- Language:English Provider:SigmaAldrich
Moxonidine hydrochloride Usage And Synthesis
Description
Moxonidine hydrochloride is a centrally acting antihypertensive agent. Mixed I1 imidazoline receptor and α2-adrenergic agonist; displays 40-fold higher affinity for I1 receptors versus α2-adrenoceptors.
Moxonidine is a selective high-affinity imidazoline I1-receptor agonist and a selectively low-affinity α2-adrenoceptor agonist. It exhibits anti-hypertensive properties by reducing blood pressure efficiently. Moxonidine also exhibits spinal analgesic activity through the α2C-adrenoceptor component.
Uses
Moxonidine is a new-generation centrally acting antihypertensive drug approved for the treatment of mild to moderate essential hypertension. It is suggested to be effective in cases where other agents such as thiazides, beta-blockers, ACE inhibitors, and calcium channel blockers are not appropriate or irresponsive. As well, moxonidine has been shown to present blood pressure-independent beneficial effects on insulin resistance syndrome.
Moxonidine hydrochloride is used as antihypertensive agent. It has been reported to produce dose-dependent analgesia in multiple acute pain assays and has been reported to potently inhibit the binding of [3H]-clonidine to VLM (ventrolateral medulla) membranes in a dose-dependent manner with the IC50 value of 53 ± 10nM.
Application
Moxonidine hydrochloride has been used:
as a standard to study its blood-brain barrier (BBB) permeability in porcine brain lipid extract by parallel artificial membrane permeability assay (PAMPA) method.
as a standard to study the chromatographic behavior and lipophilicity by reversed-phase thin-layer chromatography (RP-TLC).
as an imidazoline I1 receptor agonist to study its effects on excitatory inputs in airway vagal preganglionic neuron (AVPN).
Biological Activity
Moxonidine is a selective high-affinity imidazoline I1-receptor agonist and a selectively low-affinity α2-adrenoceptor agonist. It exhibits anti-hypertensive properties by reducing blood pressure efficiently. Moxonidine also exhibits spinal analgesic activity through the α2C-adrenoceptor component.
Moxonidine hydrochlorideSupplier
- Tel
- 0519-82765761 18001496617
- shiyf@depeichem.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 1-(800)-881-8210
- inquiries@lgmpharma.com
- Tel
- 15527768850
- 1791901229@qq.com
- Tel
- 0571-82693216
- info@yuhaochemical.com